Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GPR120 agonists(Free fatty acid receptor 4 agonists), Insulin sensitizers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 1 | US | 19 Jan 2022 | |
Fatty Liver | Preclinical | KR | - |